AstraZeneca Pharma

6,716.25
+58.80
(0.88%)
Market Cap (₹ Cr.)
₹16,674
52 Week High
7,572.20
Book Value
₹
52 Week Low
4,311.00
PE Ratio
127.28
PB Ratio
23.42
PE for Sector
50.94
PB for Sector
90.92
ROE
22.69 %
ROCE
151.90 %
Dividend Yield
0.36 %
EPS
₹52.40
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Multinational
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
29.27 %
Net Income Growth
62.66 %
Cash Flow Change
-52.19 %
ROE
34.51 %
ROCE
68.44 %
EBITDA Margin (Avg.)
-11.31 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
170
134
130
146
161
141
140
160
117
132
167
131
153
165
165
219
196
208
212
227
198
196
214
203
213
178
201
206
236
236
243
257
293
304
336
315
392
396
Expenses
128
127
132
133
156
122
135
135
115
121
129
139
135
152
147
174
184
169
175
187
180
165
174
170
170
160
180
186
194
204
195
213
265
228
258
291
334
407
EBITDA
42
7
-2
13
5
20
5
25
2
11
38
-8
18
13
18
44
12
39
37
40
18
31
40
34
43
19
21
20
42
32
48
44
28
75
78
25
58
-11
Operating Profit %
-6 %
-6 %
-3 %
8 %
-17 %
13 %
2 %
10 %
1 %
5 %
22 %
-8 %
10 %
6 %
9 %
19 %
3 %
17 %
16 %
16 %
8 %
15 %
17 %
15 %
19 %
9 %
9 %
7 %
16 %
12 %
17 %
15 %
7 %
23 %
17 %
5 %
13 %
-5 %
Depreciation
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
6
5
4
4
4
5
3
4
4
4
4
4
4
4
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
-0
0
Profit Before Tax
38
3
-7
9
1
16
1
21
-2
7
34
-12
14
9
14
41
8
34
32
35
13
26
36
28
37
14
16
16
37
27
44
39
23
71
73
20
54
-15
Tax
0
0
0
0
1
3
0
5
1
2
7
-1
2
3
4
11
-1
13
5
9
5
9
10
8
9
4
5
4
9
8
12
10
8
17
21
5
16
11
Net Profit
38
3
-7
9
1
13
1
16
-10
6
27
-10
3
6
9
29
10
22
14
27
10
19
26
21
27
10
12
11
28
20
33
29
17
54
52
16
39
-12
EPS in ₹
15.25
1.09
-2.68
3.47
0.22
5.04
0.32
6.48
-3.82
2.32
10.95
-4.14
1.29
2.58
3.65
11.64
3.93
8.61
5.77
10.68
3.83
7.45
10.54
8.42
10.91
4.10
4.78
4.57
11.19
8.06
13.03
11.72
6.91
21.54
20.95
6.32
15.79
-4.72

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
412
403
415
461
562
706
775
857
985
1,078
Fixed Assets
101
97
87
75
75
72
81
74
69
67
Current Assets
263
267
252
321
405
542
619
706
835
933
Capital Work in Progress
12
6
5
4
7
24
4
2
1
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
298
299
324
382
480
611
690
780
915
1,011
Total Liabilities
261
247
193
214
261
342
319
345
396
366
Current Liabilities
260
234
190
207
259
327
304
333
384
357
Non Current Liabilities
1
13
2
7
2
15
15
13
12
9
Total Equity
151
156
223
247
301
364
456
511
589
712
Reserve & Surplus
146
151
218
242
296
359
451
506
584
707
Share Capital
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-64
53
38
-1
59
-90
269
96
52
5
Investing Activities
-19
-4
0
-9
4
-171
173
5
18
22
Operating Activities
-46
57
38
9
55
87
105
101
58
28
Financing Activities
0
-1
0
0
0
-6
-9
-9
-24
-44

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
2.43 %
2.42 %
2.40 %
2.38 %
2.38 %
2.48 %
2.49 %
2.61 %
2.70 %
2.68 %
2.69 %
2.65 %
2.74 %
2.79 %
DIIs
0.93 %
1.02 %
1.05 %
1.14 %
1.19 %
1.30 %
1.34 %
1.44 %
1.42 %
1.93 %
2.43 %
2.78 %
3.78 %
5.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.64 %
21.56 %
21.55 %
21.48 %
21.43 %
21.22 %
21.17 %
20.96 %
20.88 %
20.40 %
19.88 %
19.57 %
18.48 %
17.20 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
27,971.60 61,353.43 49.52 6,097.18 10.80 1,201 13.01 37.10
2,698.35 47,433.69 61.58 3,576.30 6.68 590 37.87 39.33
5,667.30 27,100.04 44.97 2,373.68 -6.02 551 61.14 36.46
6,716.25 16,674.13 127.28 1,330.33 29.27 162 -121.89 47.38
7,177.55 16,544.18 33.68 2,916.40 - 603 -16.03 58.99
5,349.95 11,871.48 - 0.00 - 0 -69.11 -
5,101.20 8,505.01 39.52 1,248.01 10.68 229 -43.73 41.12

Corporate Action

Technical Indicators

RSI(14)
Neutral
47.38
ATR(14)
Volatile
219.46
STOCH(9,6)
Neutral
20.78
STOCH RSI(14)
Oversold
17.08
MACD(12,26)
Bearish
-17.14
ADX(14)
Weak Trend
18.92
UO(9)
Bearish
39.99
ROC(12)
Downtrend And Accelerating
-2.34
WillR(14)
Neutral
-63.00